Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

1 May 2014 07:00

RNS Number : 9946F
Kingspan Group PLC
01 May 2014
 



 

KINGSPAN GROUP PLC

Interim Management Statement

1st May 2014

 

Kingspan Group plc, the global leader in high performance insulation, building fabric and solar integrated building envelopes, is issuing this Interim Management Statement in advance of its Annual General Meeting which is being held today at 10.00am in Dublin.

 

Overall Kingspan has experienced a strong start to the year with Continental Europe showing tentative signs of recovery, and the UK market being relatively buoyant across all key sectors we serve. Group sales of €561m in the first four months were 8% ahead of prior year, or 9% ahead at constant exchange rates.

 

The general pick-up in activity in the UK, which we saw in the final quarter of 2013, has continued into the early part of 2014. The Benelux market has shown early signs of recovery although industry activity is at relatively low levels, and Germany remains solid. In North America, our Insulated Panel business continues to advance driven by market penetration gains, however there is limited evidence of a wider market recovery in that region. The Middle East continues to be quite active, and Australia started the year well as penetration continues to grow.

 

Insulated Panel sales revenues were up 14% (+16% constant currency) in the first four months with all key markets recording growth, reflecting both penetration gains and increased market activity, compounded by a mild winter in Europe. The sales performance also reflects a good first quarter from Kingspan Energy which should be well positioned to deliver its full year sales target. In February, we completed the acquisition of Dri-Design®, a high-end architectural façades business in the US with annual revenues of c. $25m.

 

Insulation Board sales revenues were 3% ahead (+3% constant currency) in the first four months reflecting a busier UK market and an improving environment in the Benelux, albeit off a low base. The Group's next generation Insulation, Optim-R®, entered production in the UK during the period, and a new insulation board facility in Burkhardtsdorf in eastern Germany is scheduled to be fully commissioned by mid-year.

 

Access Floor sales revenues were 9% behind (-7% constant currency) in the first four months. UK sales were ahead, driven by a lively London office market, countered by a US office environment which is stubbornly slow to recover. There is some evidence of a potential improvement in office activity in the US for 2015.

 

Environmental sales revenues in the four month period were in line with the same period last year, as the divisional activity enters a more stable phase.

 

Net debt at the 25th April was €124m an increase of €16m from the position at last year end reflecting, in part, the US façades acquisition for €23.2m. The Group's funding position is robust and, as announced recently, was further helped by the recent re-pricing and term extension of the Group's syndicated bank facility to March 2019.

 

The Board wishes to thank David Byrne and Brian Hill who will retire today as Non-Executive Directors. We are very grateful to both David and Brian for their counsel and contribution to the Board during the past nine years.

 

Looking ahead, the order backlog across the Group points towards a strong first half for the business, albeit somewhat complimented by a favourable quarter one comparative, ahead of a more demanding second quarter comparison. Activity levels generally across our markets are encouraging. We remain mindful of the prevailing geo-political uncertainty and its potential to upset what has so far been a relatively nebulous recovery. Notwithstanding this, growing conversion, a strong innovation pipeline, and the greater worldwide focus on energy efficiency, leaves us confident about Kingspan's longer term future.

 

Kingspan will issue its half-year financial report for the period ended 30 June 2014 on Tuesday 26 August 2014.

 

For further information contact:

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

Pat Walsh, Murray Consultants Tel: +353 (0) 1 4980300

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDSRXXBGSG
Date   Source Headline
6th Jan 20215:12 pmRNSHolding(s) in Company
5th Jan 20214:03 pmRNSHolding(s) in Company
4th Jan 202110:00 amRNSBlock listing Interim Review
4th Jan 20219:00 amRNSTotal Voting Rights
17th Dec 20209:00 amRNSDirectorate Change
1st Dec 20204:12 pmRNSTotal Voting Rights
16th Nov 20207:00 amRNSTrading Statement
2nd Nov 20201:04 pmRNSDirector/PDMR Shareholding
2nd Nov 202012:19 pmRNSTotal Voting Rights
15th Oct 20205:04 pmRNSDirector/PDMR Shareholding
14th Oct 20201:05 pmRNSDirector/PDMR Shareholding
1st Oct 202012:42 pmRNSTotal Voting Rights
29th Sep 20202:32 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSGreen Private Placement
1st Sep 20203:44 pmRNSTotal Voting Rights
24th Aug 20205:34 pmRNSDirector/PDMR Shareholding
24th Aug 20205:27 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSHalf-year Report
1st Jul 20206:17 pmRNSBlock listing Interim Review
1st Jul 202011:27 amRNSTotal Voting Rights
25th Jun 20203:44 pmRNSHolding(s) in Company
17th Jun 20204:51 pmRNSHolding(s) in Company
2nd Jun 20203:00 pmRNSTotal Voting Rights
1st May 20203:20 pmRNSResult of AGM
1st May 20209:45 amRNSTotal Voting Rights
30th Apr 20207:00 amRNSTrading Statement
17th Apr 20204:11 pmRNSHolding(s) in Company
17th Apr 20207:00 amRNSStatement re AGM
14th Apr 202011:41 amRNSHolding(s) in Company
1st Apr 202012:46 pmRNSTotal Voting Rights
30th Mar 202011:37 amRNSHolding(s) in Company
23rd Mar 202011:05 amRNSHolding(s) in Company
19th Mar 202012:00 pmRNSDividend Declaration
18th Mar 20209:15 amRNSHolding(s) in Company
2nd Mar 20202:23 pmRNSTotal Voting Rights
28th Feb 202010:38 amRNSAnnual Financial Report
26th Feb 20204:54 pmRNSDirector/PDMR Shareholding
24th Feb 20205:49 pmRNSHolding(s) in Company
24th Feb 20202:26 pmRNSDirector/PDMR Shareholding
24th Feb 202010:10 amRNSDirector/PDMR Shareholding
21st Feb 20207:00 amRNSFinal Results
20th Jan 20209:50 amRNSHolding(s) in Company
3rd Jan 20205:21 pmRNSHolding(s) in Company
2nd Jan 202011:00 amRNSBlock listing Interim Review
2nd Jan 202010:00 amRNSTotal Voting Rights
17th Dec 201910:45 amRNSDirector/PDMR Shareholding
11th Dec 20195:40 pmRNSDirector/PDMR Shareholding
2nd Dec 20192:58 pmRNSTotal Voting Rights
18th Nov 20197:00 amRNSTrading Update
5th Nov 201912:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.